Metraipolis › archive › dc_54379fc65fa9

MCC950 targets the ROS-NEK7-NLRP3 axis to improve type 2 diabetic retinopathy — Europe PMC PMID:40987781

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40987781
DOI
10.1038/s41598-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-09T19:30:49.214Z
SHA-256 of the archived text
c588d923369d383f0922ad7e23a2e578da077392ff6193546b5bd2573307664b
Stable URL of this page
https://metraipolis.com/documento/dc_54379fc65fa9

How to cite

MCC950 targets the ROS-NEK7-NLRP3 axis to improve type 2 diabetic retinopathy — Europe PMC PMID:40987781 — Europe PMC (en), https://europepmc.org/article/MED/40987781 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54379fc65fa9 (Metraipolis archive dc_54379fc65fa9, sha256 c588d923369d383f0922ad7e23a2e578da077392ff6193546b5bd2573307664b)
BibTeX
@misc{dc54379fc65fa9,
  title = {MCC950 targets the ROS-NEK7-NLRP3 axis to improve type 2 diabetic retinopathy — Europe PMC PMID:40987781},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40987781},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54379fc65fa9; sha256 c588d923369d383f0922ad7e23a2e578da077392ff6193546b5bd2573307664b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40987781. Agents can read the archived copy with the MCP tool read_document.